The third dopamine receptor (D3) as a novel target for antipsychotics.
Unité de Neurobiologie et Pharmacologie (U. 109) de l'INSERM, Centre Paul Broca, Paris, France.
P
P
Sokoloff
M P
MP
Martres
B
B
Giros
M L
ML
Bouthenet
J C
JC
Schwartz
D000595:Amino Acid Sequence; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D018492:Dopamine Antagonists; D006801:Humans; D008969:Molecular Sequence Data; D011487:Protein Conformation; D012333:RNA, Messenger / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects* / Q000235:genetics; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; D013687:Telencephalon / Q000378:metabolism
D014150:Antipsychotic Agents; C493593:DRD3 protein, human; D018492:Dopamine Antagonists; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3